We are building a successful company based on powerful breakthrough science.

Our company has the potential to end cancer. Period. We are fortunate to have the support of experienced life science investors who believe that we will be successful. To learn why, read more about our company and technologies. 

 

Clinical Research Sites

First Ever Preventative Cancer Vaccine Trial

Calviri is conducting the world’s largest study, Vaccine Against Canine Cancer Study (VACCS) in a trial with over 800 enrolled dogs.

Objective is to test the efficacy (over 5 years) of a preventative vaccine against the 8 most prevalent canine cancers. Double Blind, Equal Arms.

All major cancers

$6.4 Million

Study funded by a $6.4M grant from Open Philanthropy Project and Calviri, Inc

Vaccine is safe

3 independent safety board reviews find no vaccine safety issues.